|
Market Closed -
Japan Exchange
02:30:00 2026-09-11 EDT
|
5-day change | 1st Jan Change | ||
| 180.00 JPY | -24.69% |
|
-42.31% | -31.56% |
| 09-09 | StemRIM Reports Earnings Results for the Full Year Ended July 31, 2026 | CI |
| 07-22 | Stemrim Announces Patent Registration in Mexico for Redasemtide as Therapeutic Agent for Cartilage Disorders | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| STEMRIM | Biopharmaceuticals | -24.69% | -42.31% | -31.56% | -40.98% | -74.65% | 73.46M |  | | |
- Stock Market
- Stocks
- 4599 Stock
- Charts StemRIM
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
